Policy Topics | Policy Briefings

COLLAPSE

• Agriculture
• Biotechnology
• Defence & Security
• Environment
• Finance
• Fisheries and Oceans

• Foreign Policy​
• Health
• Industry and Manufacturing
• Infrastructure and Transport
• Innovation
• Intergovernmental

• Indigenous Relations
• Justice
• Labour & Employment
• Lobbying
• Natural Resources and Energy
• Women, Gender and Diversity

Biotechnology

Canada’s missing life sciences industrial strategy is leaving economic growth on the table

OpinionBY MICHELLE MCLEAN

• The federal Biomanufacturing and Life Sciences Strategy, released in 2021, did not result in needed policy changes or alignment of federal departments and investments. In contrast, other top-tier countries place life sciences at the centre of industrial strategies and align the sector with talent, trade, research and development, innovation and infrastructure. 

Canada’s missing life sciences industrial strategy is leaving economic growth on the table

OpinionBY MICHELLE MCLEAN

• The federal Biomanufacturing and Life Sciences Strategy, released in 2021, did not result in needed policy changes or alignment of federal departments and investments. In contrast, other top-tier countries place life sciences at the centre of industrial strategies and align the sector with talent, trade, research and development, innovation and infrastructure. 

PMPRB closes all open drug-pricing investigations before implementing new guidelines on Jan. 1

NewsBY TESSIE SANCI

Bloc joins push for mandatory labelling of genetically engineered foods

NewsBY TESSIE SANCI

Canada’s research strength is world-class—now we need to all pull in the same direction

OpinionBY BENOIT-ANTOINE BACON

Canada could have access to more than 10,000 doctors if licensing were less complicated, House Health Committee hears

NewsBY TESSIE SANCI

Turning innovation into impact: Canada’s biotech advantage

OpinionBY WENDY ZATYLNY

‘Cutting red tape,’ mental health and primary care on the health docket this fall

NewsBY TESSIE SANCI

Canada at risk of collateral damage in U.S. drug pricing war

OpinionBY ANNETTE ROBINSON

U.S. tariffs on pharmaceuticals could complicate an already complex supply chain

NewsBY TESSIE SANCI

MOST RECENT POLICY BRIEFINGS

Biotech

• DOWNLOAD

Biotech Policy Briefing

• DOWNLOAD

Biotechnology Policy Briefing

• DOWNLOAD

• VIEW ALL POLICY BRIEFINGS

A different ‘philosophy’ steers new drug pricing guidelines, says top PMPRB bureaucrat after contentious path to rule changes  

NewsBY TESSIE SANCI

• Guideline changes became necessary after Justin Trudeau's government chose to amend the Patented Medicines Regulations, a process beset with legal challenges and many delays.

A different ‘philosophy’ steers new drug pricing guidelines, says top PMPRB bureaucrat after contentious path to rule changes  

NewsBY TESSIE SANCI

• Guideline changes became necessary after Justin Trudeau's government chose to amend the Patented Medicines Regulations, a process beset with legal challenges and many delays.

Canada’s next top doctor must be a ‘focal point’ for public health amid changes in the U.S., concerns about next pandemic

NewsBY TESSIE SANCI

From momentum to leadership: securing Canada’s biotech future

OpinionBY WENDY ZATYLNY

Harnessing the power of Canada’s growing biotechnology industry: a perspective from the West

OpinionBY STEPHANIE WILLERTH

Biotechnology: an opportunity balanced on a knife’s edge

OpinionBY ADAM DAMRY

Biotechnology must factor into a broader Canadian industrial policy

OpinionBY FRANK BAYLIS

From crisis to catalyst: Canada’s opportunity to drive global health and research innovation

OpinionBY PAMELA SHAVER-WALKER, EDWARD SHORT

A flourishing biotech sector starts by innovating education

OpinionBY VALERIE WARD, MARC AUCOIN, HECTOR BUDMAN

The prescription for Canada’s health care future

OpinionBY BETTINA HAMELIN

AGRICULTURE

Bloc MP Perron condemns ‘ridiculous’ spending cuts that will shutter research farms across Canada

NewsBY MARLO GLASS

MPs celebrate canola tariff relief, but national security, pork, remain opposition concerns with China

NewsBY ELEANOR WAND

‘Unprecedented’ 2025 for canola industry, with record-breaking economic lobbying

NewsBY JESSE CNOCKAERT

Liberals ‘taking a sledgehammer’ to the public service, says interim NDP leader Davies

NewsBY MARLO GLASS

See all

DEFENCE & SECURITY

U.S. envoy is making Canada’s F-35 decision a no-brainer

OpinionBY SCOTT TAYLOR

Industrial benefits policy needs a ‘relook,’ says ex-senior public servant, as Conservative MP pushes for contract records

NewsBY IREM KOCA

Empower hardtech innovators to step up to sovereignty threats

OpinionBY HUGH CHOW

Time to close the U.S. arms export loophole

OpinionBY ALEX NEVE

See all

Environment

How the pursuit of innovation and sustainability can supercharge the Canadian economy

OpinionBY MARENA WINSTANLEY

Canada’s largest pension manager ‘backsliding’ on climate, risks being unable to pay out pensions: report

NewsBY ELEANOR WAND

Build more homes—but don’t lock Canada into higher emissions

OpinionBY KATE KOPLOVICH

Priorities for Canada as 2026 gets underway

OpinionBY ELIZABETH MAY

See all

FINANCE

Three measures to tackle ‘wicked’ health policy problems

OpinionBY AZIN PEYROW

‘Not a chance’: Green Leader May says she can’t support budget omnibus bill without major changes, but NDP skeptical

NewsBY STUART BENSON

MPs face a choice this Parliament: play partisan games or meet the moment

OpinionBY BHAGWANT SANDHU

IMF report says Canada’s elevated trade uncertainty reinforces long-standing weaknesses in productivity and competitiveness

OpinionBY DAVID CRANE

See all

Fisheries and oceans

Nearly 2,000 jobs and $1.5-billion to be cut across five departments by 2030, PBO analysis shows

NewsBY MARLO GLASS

Canada’s plan to boost its economy must include rebuilding wild fisheries

OpinionBY JOSH LAUGHREN

Coastal communities ‘running out of time’ without fisheries fund renewal, say opposition critics as DFO faces $544M in cuts

NewsBY STUART BENSON

Q&A | Cod quota ‘pressure is enormous’ on fisheries minister

NewsBY PETER MAZEREEUW

See all

FOREIGN POLICY

America’s drug-pricing reset will reverberate far beyond Washington

OpinionBY AKOLISA UFODIKE

Multilateralism isn’t dead—it’s being forced to deliver

OpinionBY ESTEBAN CRESPO POLO

Carney has a new moniker, Captain Canada

OpinionBY SHEILA COPPS

U.S. pressures Canada to roll back on data sovereignty, a high-priority issue in CUSMA renegotiation

OpinionBY DAVID CRANE

See all

health

‘Diseases do not recognize borders’: U.S. decision to leave WHO ignores reality of how diseases spread, says Liberal MP Powlowski

NewsBY TESSIE SANCI

Lack of flexibility, questions about long-term funding have been stumbling blocks in signing pharmacare deals, say some premiers

NewsBY TESSIE SANCI

Health workforce, toxic drug crisis on health critics’ agendas this winter

NewsBY TESSIE SANCI

Make federal funding permanent for Canada’s suicide crisis helpline, say Conservative and NDP critics

NewsBY TESSIE SANCI

See all

Industry and Manufacturing

Canada’s auto sector ‘hangs in the balance’ as CUSMA review looms in 2026: ‘there’s no sugar-coating it, this is going to be a critical year for the industry’

NewsBY JESSE CNOCKAERT

Renewable energy sector adds concerns about wind-tower costs to steel industry crisis talks: ‘there’s a ton of urgency’

NewsBY JESSE CNOCKAERT

Steel tariff missteps threaten Canada’s energy future

OpinionBY VITTORIA BELLISSIMO, FERNANDO MELO

‘Quiet buzz’ on Bay Street about Carney’s ‘nation-building’ major projects, says Tobin

NewsBY CHRISTOPHER GULY

See all

infrastructure and transport

Health organizations have questions, but few answers about feds’ new $5-billion Health Infrastructure Fund

NewsBY TESSIE SANCI

Can Build Canada Homes make a dent in the housing crisis?

OpinionBY ALAN BROADBENT

The joys of winter biking aren’t without politics

OpinionBY ANDREW CADDELL

Time to strengthen Canada’s infrastructure planning 

OpinionBY JENNIFER ANGEL, PETER WELTMAN

See all

innovation

Taking a stand for sovereignty

OpinionBY CATHERINE TAIT

Transforming Canada’s energy abundance into economic leadership in the AI age

OpinionBY PETER MASSIE, CHRISTOPHER COLLINS

The missing mandate in Canadian innovation policy

OpinionBY CONSERVATIVE MP RAQUEL DANCHO

Canada’s AI moment is a values-based one

OpinionBY KRISTEN CORDELL, SABEEN DHANANI

See all

intergovernmental

Referendum fever: it’s like Waiting for Godot

OpinionBY NELSON WISEMAN

Canada’s housing crisis isn’t just about building more—it’s about getting governments to talk to each other

OpinionBY ADRIAN SCHUT

Bravo to Carney for speaking the truth

OpinionBY ANDREW CADDELL

A shifting geopolitical environment leaves the Arctic central to Canada’s sovereignty and security

OpinionBY NDP MP LORI IDLOUT

See all

justice

Emergencies Act architect says courts checked government overreach, advises against further appeal

NewsBY STUART BENSON

America lost justice when Renee Nicole Good was killed

OpinionBY MICHAEL HARRIS

We need to go beyond criminal law reform to end gender-based violence

OpinionBY LANA WELLS

Bill C-16 ‘progress,’ but needs tougher language to codify femicide as a standalone crime, advocates say

NewsBY MARLO GLASS

See all

Labour & employment

Solving Canada’s housing crisis starts with a reality check

OpinionBY JANICE MYERS

Build Canada Homes is poised to make a generational investment in non-market and public housing—but will it?

OpinionBY MARC LEE

A home is a human right: why inclusion must be built in

OpinionBY JANET FORBES, BEN ROWLEY

Housing is reconciliation: why Canada must prioritize Indigenous housing

OpinionBY MARGARET PFOH

See all

Lobbying

Ottawa’s lowered lobbying registration thresholds will reshape government relations

OpinionBY SUZANNE SABOURIN, MICHAEL WALSH

Libya was a warning, Venezuela is the test

OpinionBY AKOLISA UFODIKE

‘It’s like molasses in January’: pharmacare implementation stalled, say health-care groups, but others argue time needed to get deals right

NewsBY JESSE CNOCKAERT

Joly top-lobbied minister in November, universities push to attract research talent driven away from U.S.

NewsBY JESSE CNOCKAERT

See all

natural resources and energy

Canada’s green jobs strategy needs more than good intentions

OpinionBY LIN AL-AKKAD

Federal environmental impact assessments are in even more jeopardy   

OpinionBY KEN RUBIN

Trump’s hit on Venezuela just gave Canada a bruise

OpinionBY ERICA IFILL

Buried in the MOU: a licence to lie

OpinionBY LEAH TEMPER, SAMANTHA GREEN

See all

Women, Gender and Diversity

Governments can do more to fight against Islamophobia

OpinionBY WAHEED KHAN

Women entrepreneurs are a crucial asset for Canada’s economy, they deserve a voice in shaping it

OpinionBY ROSALIND LOCKYER

Artificial action: feds offering tepid response to AI abuse

OpinionBY ERICA IFILL

When a parliamentary committee recently politicized EDI in research, they put Canadian science and patient care at risk

OpinionBY RACHEL REEVE

See all

Indigenous Relations

Indigenous innovation: part of the tradition, not the trend

OpinionBY KATHY MANNERS

‘The ground on which we stand’: innovation and Indigenous sovereignty

OpinionBY JESSICA KOLOPENUK

‘I will always be an advocate,’ says retiring Indigenous senior civil servant Gina Wilson after decades working to ‘bridge worlds’

NewsBY ELEANOR WAND

Principled-based pragmatism and the wisdom of the seven generations

OpinionBY ROSE LEMAY

See all

Upcoming Policy briefings

Exclusive lists

Who’s backing the NDP leadership contenders?

Who’s backing the NDP leadership contenders?

Tracking job cuts in the federal public service

Tracking job cuts in the federal public service

Take The Hill Times year-end news quiz

Take The Hill Times year-end news quiz

First-quarter expenses: MPs spent nearly $28-million

First-quarter expenses: MPs spent nearly $28-million

This Parliament’s ethics roundup: blind trusts, recusals, gifts, and more

This Parliament’s ethics roundup: blind trusts, recusals, gifts, and more

Take The Hill Times politics quiz

Take The Hill Times politics quiz

Carney government bills: tracking their progress into law

Carney government bills: tracking their progress into law

The number of sick days claimed by bureaucrats, broken down by department

The number of sick days claimed by bureaucrats, broken down by department